Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 780 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Mitsubishi to withdraw from fine chemical business

The Pharmaceutical ingredient manufacturing and sales operations will be transferred to API Corporation and food chemical operations will be transferred to Taisho Technos, effective 1 July 2012. API